论文部分内容阅读
比佛拉唑(bifonazole, bay h 4502,商品名mycosper)是最先由联邦德国贝尔研究中心合成的一种新型咪唑类局部抗真菌药.该药于1978年起进行临床实验,并于1982年在德国正式登记注册.理化性质比佛拉唑为氮取代性不含卤
Bifonazole (bifonazole, bay h 4502, trade name mycosper) is the first novel imidazole topical antifungal agent to be synthesized by the Bell Laboratories of the Federal Republic of Germany. The drug was started in 1978 and was tested in 1982 Officially registered in Germany. Physicochemical properties Biflavazole nitrogen-substituted Halogen-free